The treatment of COVAN is typically supportive with interventions including dietary sodium restriction of 2.3 g/day, optimization of hyperlipidemia and hypertension, blockade of the renin-angiotensin-aldosterone system, sodium/glucose cotransporter-2 inhibition, and maintenance of euvolemia. The gene discussed is REN; the disease is hypertensive disorder.